Advanced search×

Impact of the metabolic syndrome on subcutaneous microcirculation in obese patients.

J Hypertens 28(8):1708-14 (2010) PMID 20520576

Patients with the metabolic syndrome are at increased cardiovascular risk and display an augmented wall stiffness of the large-sized and medium-sized arteries, coupled with an endothelial dysfunction. Whether this is the case also for the small resistance arteries is unknown, however. It is also unknown whether and to what extent the hypothesized microvascular alterations are greater for magnitude than the ones characterizing obesity, that is the most common component of the metabolic syndrome.

DOI: 10.1097/HJH.0b013e32833af3c9
Version: za2963e q8za4 q8zb2 q8zc7 q8zd0 q8ze8 q8zfb q8zgb

Similar articles you may find interesting…

  1. Fatal B-cell Lymphoma Following Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids.

    JAMA Neurology (2013) PMID 23649857

    We report on a well-documented patient who presented with clinical, radiological, and pathological characteristics of CLIPPERS and who had an unfavorable outcome. OBSERVATIONS We present the clinical, imaging, laboratory, brain biopsy, and autopsy findings of a 57-year-old male patient with CLIPPERS...
  2. Characterization of a short isoform of the kidney protein podocin in human kidney.

    BMC Nephrol 14(1):102 (2013) PMID 23648087

    A second isoform of human podocin is expressed in the kidney. This isoform lacks part of the PHB domain. It can be detected on protein level. Distinct subcellular localization suggests a physiological role for this isoform which may be different from the well-studied canonical variant. Possibly, the...
  3. Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain.

    Health Econ Rev 3(1):13 (2013) PMID 23647721

    Fingolimod therapy requires twice the investment as glatiramer acetate....